Unlock stock picks and a broker-level newsfeed that powers Wall Street.

ASX - Delayed Quote AUD

Anatara Lifesciences Ltd (ANR.AX)

Compare
0.0060
0.0000
(0.00%)
At close: 2:06:42 PM GMT+10
Currency in AUD All numbers in thousands
Breakdown
TTM
6/30/2024
6/30/2023
6/30/2022
6/30/2021
Operating Expense
2,103.1530
2,103.1530
3,284.9240
3,022.2130
3,112.7180
Operating Income
-2,103.1530
-2,103.1530
-3,284.9240
-3,022.2130
-3,112.7180
Net Non Operating Interest Income Expense
7.8850
7.8850
15.8900
2.6850
8.8160
Other Income Expense
644.0260
644.0260
1,245.8460
487.2350
1,108.0280
Pretax Income
-1,451.2420
-1,451.2420
-2,023.1880
-2,532.2930
-1,995.8740
Net Income Common Stockholders
-1,451.2420
-1,451.2420
-2,023.1880
-2,532.2930
-1,995.8740
Basic EPS
-0.01
--
-0.02
-0.03
-0.03
Diluted EPS
-0.01
--
-0.02
-0.03
-0.03
Basic Average Shares
150,016.5720
--
104,303.3140
78,218.3630
68,952.6240
Diluted Average Shares
150,016.5720
--
104,303.3140
78,218.3630
68,952.6240
Net Income from Continuing & Discontinued Operation
-1,451.2420
-1,451.2420
-2,023.1880
-2,532.2930
-1,995.8740
Normalized Income
-1,451.2420
-1,451.2420
-2,023.1880
-2,532.2930
-1,995.8740
Interest Income
7.8850
7.8850
18.2600
6.0050
9.1160
Interest Expense
--
--
2.3700
3.3200
0.3000
Net Interest Income
7.8850
7.8850
15.8900
2.6850
8.8160
EBIT
-2,103.1530
-2,103.1530
-2,020.8180
-2,528.9730
-1,995.5740
EBITDA
-2,100.6900
-2,100.6900
-1,996.0550
-2,504.2960
-1,989.3090
Reconciled Depreciation
2.4630
2.4630
24.7630
24.6770
6.2650
Net Income from Continuing Operation Net Minority Interest
-1,451.2420
-1,451.2420
-2,023.1880
-2,532.2930
-1,995.8740
Normalized EBITDA
-2,100.6900
-2,100.6900
-1,996.0550
-2,504.2960
-1,989.3090
6/30/2021 - 10/15/2014

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers